BioPorto A/S
BIOPOR
Rank in Stocks
#22971
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Share Price
$0.15400149
Market Cap
$76.25M
Change (1 day)
-5.83%
Change (1 year)
-46.53%
Country
DK
Trade BioPorto A/S (BIOPOR)
Category
Healthcare
Stock price history for BioPorto A/S (BIOPOR)
Highest end of day price: $0.15 on 2026-10-01
Lowest end of day price: $0.41 on 2019-12-01
Lowest end of day price: $0.41 on 2019-12-01
Stock price history of BioPorto A/S from 2019 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -35.32% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $693.77 | 24.33% |
US
|
|
| $230.51 | 4.41% |
US
|
|
| $417.96 | 123.65% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.29 | 21.70% |
US
|
